Topiramate 61919-0213
Product NDC
61919-0213- Manufacturer
- C
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 17, 2024
- Listing Expires
- December 31, 2027
- Application
- ANDA076343
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 100 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(4)
30 TABLET in 1 BOTTLE (61919-213-30)
60 TABLET in 1 BOTTLE (61919-213-60)
120 TABLET in 1 BOTTLE (61919-213-72)
90 TABLET in 1 BOTTLE (61919-213-90)